Rankings
▼
Calendar
ARVN
Arvinas, Inc.
$856M
Q2 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$2M
100.0% margin
Operating Income
-$7M
-403.0% margin
Net Income
-$7M
-400.2% margin
EPS (Diluted)
$-3.52
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$83,885
← FY 2017
All Quarters
Q3 2017 →
ARVN Q2 2017 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena
